email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
61 - 75
of 3615 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Qilu Says PD-1/CTLA-4 Combo Effective Against Cervical Cancer
$5.00
Available
CARsgen Approved to Launch BMA CAR-T in China for Multiple Myeloma
$5.00
Available
Innovent Starts Trials of Bispecific Antibody for Severe Asthma
$5.00
Available
Mabwell Out-Licenses Rare Disease Therapy to Disc in $412 Million Deal
$5.00
Available
AstraZeneca to Build Global Strategic Center in Shanghai
$5.00
Available
Biotheus to Develop Antibodies With Bitterroot for Cardio-Immunology
$5.00
Available
AstraZeneca to Continue Roxadustat Sales in China; Returns Other Rights
$5.00
Available
Everest Medicines Approved to Start China Phase IIb Trial of Lupus Therapy
$5.00
Available
Nhwa to Distribute Teva’s Movement Disorder Therapies in China
$5.00
Available
BioCity Completes Enrollment of ETA Agonist Trial in Patients with IgA Nephropathy
$5.00
Available
Longbio of Suzhou Says LP-003 Effective in Patients with Allergic Rhinitis
$5.00
Available
CHMP Recommends Approval of Legend’s CAR-T as Second-Line Multiple Myeloma Therapy
$5.00
Available
Immunofoco to Start US Trial of CAR-T for Gastrointestinal Tumors
$5.00
Available
Simcere Announces Positive Data from Phase III Trial of Dual-Drug Oral Therapy for Stroke
$5.00
Available
Innovent’s IGF-1R Antibody Meets Endpoint for Thyroid Eye Disease
$5.00
Available